Before you take a new drug, ask your doctor or pharmacist questions like: Can I take this with my other meds? Should I avoid certain foods, drinks, or other products? Could this medication ...

Remember, you should not change your dosage of Vraylar without your doctor’s recommendation. Only take Vraylar exactly as prescribed. Talk with your doctor if you have questions or concerns ...

There isn’t an alternative dosing schedule recommended for the drug. Talk with your doctor if you have questions about Wegovy’s dose schedule. Why is there a starting dose for Wegovy?

Whether you are beginning your career, looking to change your career or desire an advanced degree, Passan School of Nursing is the place for you. Our school has a strong commitment to the professional ...

A practice–focused terminal degree, the Doctor of Nursing Practice (DNP) Program prepares graduates to lead the translation of scientific evidence into best practices for improving population health ...

But with too few staff and inadequate gear, they’re no match for the most dangerous threat now lurking in the national parks, violent drug cartels.

Questions remain over the efficacy-to-safety ratio of Novo Nordisk’s acquired weight loss drug monlunabant after a Phase IIa trial. The pharma giant announced results from the study (NCT05891834 ...

A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore General ...

How has Alzheimer's affected your family? What are your questions about the disease and the breakthrough drug? You can get in touch by emailing [email protected]. Please include a contact ...

It was released in advance of a United Nations General Assembly meeting later this month on drug-resistant pathogens. “The numbers in the Lancet paper represent a staggering and unacceptable ...

There have been 22 reports of drug dealing at the Royal Victoria Hospital in 2024. Andrew says his son was "set up to fail" by the government's early release scheme for prisoners. The Belfast ...

Sept 11 (Reuters) - Staff reviewers at the U.S. Food and Drug Administration said on Wednesday a confirmatory trial did not show the effectiveness of Intercept's liver disease drug, which received ...